New CDC data strengthen the evidence that the risk for Guillain-Barré syndrome (GBS) associated with the 2009 H1N1 vaccine is similar to the risk seen with seasonal flu vaccines, according to an MMWR report.
SPECIAL REPORT Information Technology and Global Surveillance of Cases of 2009 H1N1 Influenza J.S. Brownstein and Others Although formal reporting, surveillance, and response structures remain essential to protecting public health, a new generation of freely accessible, online, and real-time informatics tools for disease tracking are expanding the ability of public health professionals to detect weak [...]
The CDC reports an increase in H1N1-related hospitalizations in Georgia and a few other southeastern states, particularly among adults with certain chronic conditions (e.g., diabetes, COPD, heart disease).
Estimates of 2009 H1N1 influenza cases in the U.S. from April 2009 to mid-January 2010 ranged widely, from 41 million to 84 million, according to the CDC.
More in this category
- Incidence and Case Fatality Rates of Novel 2009 Pandemic A/H1N1 Influenza in England
- WHO Addresses Vaccine Anaphylaxis, Drug Resistance, H1N1 Mutations
- U.S. Influenza Activity Decreased Slightly in Last Week
- Estimates of Flu’s Toll; Seasonal Vaccine Not Effective Against 2009 H1N1
- No Resurgence — Yet — in Cities Hardest Hit by H1N1 Last Spring
- Neurologic Complications Observed in Children with Novel H1N1